Search - tctmd.com

Displaying 21 - 40 of 63

Sort: Relevancy | Date

News Conference News ESC 2017

Fentanyl, Ubiquitous in US Cath Labs, Blunts Antiplatelet Drugs in PCI

Shelley Wood

September 01, 2017

News Conference News ESC 2017

P2Y12 Inhibitor Pretreatment Questioned in STEMI

Todd Neale

August 29, 2017

News Conference News ESC 2017

ESC Updates Guidelines for Treating STEMI Patients

Michael O'Riordan

August 27, 2017

News Daily News

Faster Primary PCIs Linked to Higher Stent Thrombosis Risk With Bivalirudin

Todd Neale

March 07, 2017

News Daily News

With No RCTs, Propensity-Score Matched Analysis Informs Choice Between Cangrelor and GPIs in the Cath Lab

Yael L. Maxwell

December 06, 2016

News Daily News

Sin ECA, el Análisis de Emparejamiento por Puntuación de la Propensión permite tomar una Decisión Informada entre Cangrelor y GPI en el Laboratorio de Cateterización

Yael L. Maxwell

December 06, 2016

News Conference News TCT 2016

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Yael L. Maxwell

October 31, 2016

News Daily News

Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests

Yael L. Maxwell

June 20, 2016

News Conference News ACC 2016

More Evidence That Morphine Hampers Effects of Antiplatelet Therapy in STEMI

Todd Neale

April 02, 2016

News Daily News

导管室并发症：新的分析精准确定了 ACS 患者术中血栓事件的事件率及风险

Shelley Wood

January 21, 2016

News Daily News

Complicaciones en el Laboratorio de Cateterización: Un Nuevo Análisis Define el Índice y Riesgos de los Episodios Trombóticos Intraoperatorios en el Manejo del SCA

Shelley Wood

January 21, 2016

News Daily News

Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS

Shelley Wood

January 21, 2016

News Daily News

Surgery Common in Stented Patients But Newer Stents Appear to Reduce Potential Risks

Michael O'Riordan

December 07, 2015

News Conference News TCT 2015

Experts Debate Optimal Pharmacologic Approach for STEMI Patients

October 11, 2015

News Daily News

在PCI患者中切入部位和坎格雷洛之间没有相互作用

Caitlin E. Cox

October 06, 2015

News Daily News

No Interplay Between Access Site, Cangrelor Effects in PCI Patients

Caitlin E. Cox

October 06, 2015

News Daily News

No hay interacción entre el punto de acceso y los efectos del Cangrelor en pacientes con PCI

Caitlin E. Cox

October 06, 2015

Presentation

CHAMPION PHOENIX: Effect of Cangrelor and Access Site on Ischemic and Bleeding Events

Presenter: JA. Gutierrez

October 05, 2015

News Daily News

房颤患者过渡治疗无法预防血栓栓塞，且会增加出血

Yael L. Maxwell

July 10, 2015

News Daily News

La Terapia Puente para Pacientes con FA No Previene los Tromboembolismos y Aumenta las Hemorragias

Yael L. Maxwell

July 10, 2015

Advertisement

Fentanyl, Ubiquitous in US Cath Labs, Blunts Antiplatelet Drugs in PCI

P2Y12 Inhibitor Pretreatment Questioned in STEMI

ESC Updates Guidelines for Treating STEMI Patients

Faster Primary PCIs Linked to Higher Stent Thrombosis Risk With Bivalirudin

With No RCTs, Propensity-Score Matched Analysis Informs Choice Between Cangrelor and GPIs in the Cath Lab

Sin ECA, el Análisis de Emparejamiento por Puntuación de la Propensión permite tomar una Decisión Informada entre Cangrelor y GPI en el Laboratorio de Cateterización

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests

More Evidence That Morphine Hampers Effects of Antiplatelet Therapy in STEMI

导管室并发症：新的分析精准确定了 ACS 患者术中血栓事件的事件率及风险

Complicaciones en el Laboratorio de Cateterización: Un Nuevo Análisis Define el Índice y Riesgos de los Episodios Trombóticos Intraoperatorios en el Manejo del SCA

Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS

Surgery Common in Stented Patients But Newer Stents Appear to Reduce Potential Risks

Experts Debate Optimal Pharmacologic Approach for STEMI Patients

在PCI患者中切入部位和坎格雷洛之间没有相互作用

No Interplay Between Access Site, Cangrelor Effects in PCI Patients

No hay interacción entre el punto de acceso y los efectos del Cangrelor en pacientes con PCI

CHAMPION PHOENIX: Effect of Cangrelor and Access Site on Ischemic and Bleeding Events

房颤患者过渡治疗无法预防血栓栓塞，且会增加出血

La Terapia Puente para Pacientes con FA No Previene los Tromboembolismos y Aumenta las Hemorragias

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content